Landscape Capital Management’s Charles River Laboratories CRL Stock Holding History

Landscape Capital Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-8,002	Closed	-$1.6M	–	773
2025 Q4	$1.6M	Buy	8,002 +1,030	+15%	+$187K	0.11%	284
2025 Q3	$1.09M	Buy	+6,972	New	+$1.11M	0.07%	353
2025 Q2	–	Sell	-3,345	Closed	-$503K	–	682
2025 Q1	$503K	Buy	+3,345	New	+$561K	0.04%	412
2020 Q1	–	Sell	-10,233	Closed	-$1.56M	–	638
2019 Q4	$1.56M	Sell	10,233 -1,534	-13%	-$212K	0.11%	227
2019 Q3	$1.56M	Buy	+11,767	New	+$1.58M	0.11%	199
2018 Q4	–	Sell	-2,162	Closed	-$291K	–	875
2018 Q3	$291K	Buy	+2,162	New	+$267K	0.02%	561

Other funds holding CRL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Landscape Capital Management's CRL Position: Q1 2026 in Review

Landscape Capital Management sold out of Charles River Laboratories (CRL) in Q1 2026, closing a stake of 8,002 shares — an estimated $1.6M sold.

Landscape Capital Management first reported a position in CRL in Q3 2018 and held it in 6 quarters. The position peaked at $1.6M in Q4 2025. 557 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

Landscape Capital Management reported no remaining Charles River Laboratories position as of Q1 2026 after selling out during the quarter.
Landscape Capital Management sold 8,002 Charles River Laboratories shares in Q1 2026, an estimated $1.6M.
Landscape Capital Management first reported a position in Charles River Laboratories in Q3 2018 and held it in 6 quarters.
Landscape Capital Management's Charles River Laboratories position peaked at $1.6M in Q4 2025.
557 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Landscape Capital Management's 13F filing for Q1 2026, filed 12 May 2026.